Giordano Madeddu to Coronavirus Infections
This is a "connection" page, showing publications Giordano Madeddu has written about Coronavirus Infections.
Connection Strength
0.078
-
Reply Letter - "Safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: a nationwide comparative analysis". Eur Rev Med Pharmacol Sci. 2021 03; 25(5):2161-2162.
Score: 0.029
-
Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy. Eur Rev Med Pharmacol Sci. 2020 07; 24(14):7861-7868.
Score: 0.028
-
Severity of lung involvement on chest X-rays in SARS-coronavirus-2 infected patients as a possible tool to predict clinical progression: an observational retrospective analysis of the relationship between radiological, clinical, and laboratory data. J Bras Pneumol. 2020; 46(5):e20200226.
Score: 0.007
-
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study. Head Neck. 2020 Jul; 42(7):1560-1569.
Score: 0.007
-
Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases. Head Neck. 2020 06; 42(6):1252-1258.
Score: 0.007